Incidence of cancer set to rise: Lancet study
The HinduBetween 2018 and 2040, the number of patients requiring first-course chemotherapy annually will increase from 9.8 million to 15 million. A study published in The Lancet, Oncology estimates that a steady growth curve of patients will be seen in low and middle income countries going from 63% in 2018 to 67% in 2040. “We estimated that in 2018, 65,000 cancer physicians were required worldwide to deliver optimal chemotherapy — a figure that we estimate will rise to 1,00,000 by 2040 [with estimates ranging from 50,000 to 1,50,000 depending on workload,’’ the study noted. “Strategic investments in chemotherapy service provision and cancer physicians are needed to meet the projected increased demand for chemotherapy in 2040,’’ it said. The study conducted by researchers, including those at the UNSW Sydney, the Ingham Institute for Applied Medical Research, the Liverpool Cancer Therapy Centre and the International Agency for Research on Cancer, Lyon looked at data for the incidence of 29 types of cancer in 183 countries in 2018, and projections of incidence in 2040, were obtained.